Hinge Health is trading at $100.86, a change of -4.07%, as hotter-than-expected September inflation weighs on equities.

  • The S&P 500 and Nasdaq are also lower; rising yields and interest-rate concerns are pressuring growth-sensitive stocks.
  • No clear company-specific catalyst was identified.
  • Executives’ October 12 share sales were made under pre-arranged trading plans; available evidence does not establish them as the cause.